Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy

被引：0
|
作者：
D. Gibellini
M. Borderi
E. Vanino
A. Clò
S. Morini
L. Calza
M. C. Re
Pl. Viale
机构：
[1] University of Bologna,Department of Haematology and Oncological Sciences, Microbiology Section
[2] University of Bologna,Department of Internal Medicine, Aging and Nephrology, Infectious Diseases Section
来源：
Clinical Reviews in Bone and Mineral Metabolism | 2012年 / 10卷 / 4期
关键词：
HIV; Bone; Osteopenia/osteoporosis; Virus; Antiretrovirals;
D O I：
10.1007/s12018-012-9133-y
中图分类号：
学科分类号：
摘要：
In addition to immune system, HIV infection can determine the onset of functional dysfunctions of several organs and tissues such as central nervous system, cardiovascular system, kidney, and bone. It is noteworthy that HIV-infected individuals show an increased risk of bone mass loss with subsequent osteopenia and osteoporosis development. Interestingly, antiretroviral therapy is not able to tackle the bone derangement but, on the contrary, it can induce a progressive bone mass loss, especially when specific antiretroviral drugs are used. In this report, we summarized the HIV and antiretroviral-related mechanisms involved in the osteopenia and osteoporosis induction.
引用
收藏
页码：236 / 245
页数：9
相关论文
共 50 条
  • [21] Effect of Antiretroviral HIV Therapy on Hepatitis B Virus Replication and Pathogenicity
    Guertler, Lutz G.
    INTERVIROLOGY, 2014, 57 (3-4) : 212 - 217
  • [22] Impact of Hepatitis C Virus on HIV Response to Antiretroviral Therapy in Nigeria
    Agbaji, Oche
    Thio, Chloe L.
    Meloni, Seema
    Graham, Camilla
    Muazu, Mohammed
    Nimzing, Ladep
    Idoko, John
    Sankale, Jean-Louis
    Ekong, Ernest
    Murphy, Robert
    Kanki, Phyllis
    Hawkins, Claudia
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (02) : 204 - 207
  • [23] Towards a molecular profile of antiretroviral therapy-free HIV remission
    Adams, Philipp
    Berkhout, Ben
    Pasternak, Alexander O.
    CURRENT OPINION IN HIV AND AIDS, 2022, 17 (05) : 301 - 307
  • [24] Antiretroviral therapy for HIV infection
    Lozano, Fernando
    Domingo, Pere
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (06): : 455 - 465
  • [25] ANTIRETROVIRAL THERAPY AGAINST HIV
    GONZALEZLAHOZ, J
    SORANO, V
    MEDICINA CLINICA, 1995, 105 (10): : 377 - 378
  • [26] Antiretroviral therapy in primary HIV
    Corey, L
    Berrey, MM
    ANTIVIRAL CHEMOTHERAPY 5: NEW DIRECTIONS FOR CLINICAL APPLICATION AND RESEARCH, 1999, 458 : 223 - 227
  • [27] Role of β-Klotho and Malondialdehyde in Metabolic Disorders, HIV Infection, and Antiretroviral Therapy
    Elena Gutierrez-Perez, Maria
    Ivonne Urraza-Robledo, Arguine
    Alejandro Miranda-Perez, Alberto
    Anali Molina-Flores, Cinthia
    Ruiz-Flores, Pablo
    Delgadillo-Guzman, Dealmy
    Carlos Lopez-Marquez, Francisco
    DNA AND CELL BIOLOGY, 2022, 41 (07) : 691 - 698
  • [28] Role of demographic and clinical factors in survival of HIV patients on antiretroviral therapy
    Desai, Kanan T.
    Patel, Fenil
    Patel, Prakash B.
    Bansal, R. K.
    TROPICAL DOCTOR, 2021, 51 (03) : 403 - 408
  • [29] Evolution of hepatitis C virus in HIV coinfected patients under antiretroviral therapy
    Sede, Mariano
    Parra, Micaela
    Manrique, Julieta M.
    Laufer, Natalia
    Jones, Leandro R.
    Quarleri, Jorge
    INFECTION GENETICS AND EVOLUTION, 2016, 43 : 186 - 196
  • [30] Modification of antiretroviral therapy for concurrent treatment of HIV and hepatitis C virus infection
    Campos-Davila, E.
    Tellez-Perez, F.
    Guerra-Estevez, D.
    Ramos-Baez, J. J.
    Roldan-Morales, J. C.
    Villanueva, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 574 - 574
12345